Chapter 1 Introduction
1.1 Executive Summary
1.2 Market Definition
1.3 Scope of the Study
Chapter 2 Research Methodology
2.1 Secondary Research
2.2 Primary Research
2.3 Analytic Tools and Model
2.4 Economic Indicator
2.4.1 Base Year, Base Currency, Forecasting Period
2.5 Expert Validation
2.6 Study Timeline
Chapter 3 Market Analysis
3.1 Industry Value Chain Analysis
3.2Porter's Five Force Analysis
3.2.1 Bargaining Power of Buyers
3.2.2 Bargaining Power of Suppliers
3.2.3 Threats of Substitutes
3.2.4 Threats of New Entrants
3.2.5 Industry Rivalry
3.3 Pestle Analysis
3.3.1 Political
3.3.2 Economical
3.3.3 Social
3.3.4 Technological
3.3.5 Legal
3.3.6 Environmental
3.4 SWOT Analysis
3.4.1 Strengths
3.4.2 Weakness
3.4.3 Opportunities
3.4.4 Threats
3.5 Y-O-Y Analyses
Chapter 4 Market Dynamics
4.1. Drivers
4.1.1 Increasing demand for personalised medicine
4.1.2 Technical advancements
4.1.3 Availability of government funding
4.1.4 High investments by private players and governments in R & D
4.2 Restraints
4.2.1 Lack of skilled personnel to carry out the procedure
4.2.2 High cost of instruments and tools
4.3 Opportunities
4.3.1 Increasing growth opportunities in emerging markets
4.4 Challenges
4.4.1. A dearth of skilled researchers
4.4.2 Adoption of hyphenated Technologies
Chapter 5 Asia Pacific Metabolomics Market – By Technique
5.1 Detection Techniques
5.1.1 Multivariate Analysis
5.1.2 Mass Spectrometry
5.1.3 Spectroscopy
5.1.3.1 Nuclear Magnetic Resonance Spectroscopy
5.1.3.2 Fourier Transform Infrared Spectroscopy
5.2 Separation Techniques
5.2.1 Liquid Chromatography
5.2.1.1 High-Performance Liquid Chromatography
5.2.1.2 Ultra Performance Liquid Chromatography
5.2.2 Gas Chromatography
5.2.3 Capillary Electrophoresis
Chapter 6 Asia Pacific Metabolomics Market - By Applications
6.1 Biomarker Discovery
6.2 Personalized medicine
6.3 Toxicology testing
6.4 Agriculture and Environmental industries
Chapter 7 Asia Pacific Metabolomics Market - By Country
7.1 Introduction
7.2 Asia Pacific
7.2.1 China
7.2.2 India
7.2.3 Japan
7.2.4 South Korea
7.2.5. Australia & New Zealand
7.2.6. Rest of APAC
Chapter 8 Asia Pacific Metabolomics Market - Company Profiles
8.1. Leco
8.2 Agilent Technologies, Inc
8.3 Danaher Corporation
8.4. Bio-Rad Laboratories, Inc.
8.5. Waters Corp.
8.6. Shimadzu Corporation
8.7 Thermo Fisher Scientific Inc.
8.8 Human Metabolome Technologies, Inc.
8.9 Biocrates Life Sciences AG.
8.10 Metabolon, Inc.
8.11. Leco Corporation
8.12. Bruker Corporation
8.13. GE Healthcare
8.14. PerkinElmer, Inc
8.15. Roche Diagnostics
Chapter 9 Asia Pacific Metabolomics Market - Competitive Landscape
9.1. Market Share Analysis
9.2. Strategies Adopted by top companies
9.3. Mergers, Acquisitions, Collaborations & Agreements
Chapter 10 Market Insights
10.1. Industry Experts Insights
10.2. Analysts Opinions
10.3. Investment Opportunities
Chapter 11 Appendix
11.1 List of Tables
11.2 List of Figures
